Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results

WALTHAM, Mass., Oct. 22 Inverness MedicalInnovations, Inc. (Amex: IMA), a global leader in rapid point-of-carediagnostic products, today announced that it will release its third quarter2008 earnings on Wednesday, October 29, 2008. The Company will also host aconference call beginning at 10:00 a.m. (Eastern Time) on that date to discussthese results and other corporate matters. During the conference call theCompany may discuss and answer questions concerning business and financialdevelopments and trends. The Company's responses to questions, as well asother matters discussed during the conference call, may contain or constituteinformation that has not been disclosed previously.

The conference call may be accessed by dialing 973-582-2700 (domestic andinternational), an access code is not required, or via a link on the Invernesswebsite at http://www.invernessmedical.com. It is also available via link athttp://tinyurl.com/67ankb using Real Player or Windows Media. An on-demandwebcast of the call will be available at the Inverness website(www.invernessmedical.com/News.cfm) two hours after the end of the call andwill be accessible for 30 days.

By developing new capabilities in near-patient diagnosis, monitoring andhealth management, Inverness Medical Innovations enables individuals to takecharge of improving their health and quality of life. A global leader inrapid point-of-care diagnostics, Inverness' products, as well as its newproduct development efforts, focus on infectious disease, cardiology,oncology, drugs of abuse and women's health. Inverness is headquartered inWaltham, Massachusetts.

For additional information on Inverness Medical Innovations, please visitwww.invernessmedical.com.

SOURCE Inverness Medical Innovations, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...